SCHEMBL17825422

SCHEMBL17825422

Cn1nnnc1Cn1c(=O)[nH]c2ccc(S(N)(=O)=O)c(C3(C)CC3)c2c1=O

nearest known ligand 0.39

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PARG Q86W56 14/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17825421 0.70 PARG (0.70) PARG
SCHEMBL17825247 0.69 PARG (0.53) PARG
SCHEMBL17825358 0.69 PARG (0.53) PARG
SCHEMBL6395227 0.57 ADORA2B (0.44)
SCHEMBL6388376 0.57 CYP1A2 (0.52) PARG
SCHEMBL6388296 0.56 ADORA2B (0.46)
SCHEMBL17845518 0.55
SCHEMBL6386965 0.55 FEN1 (0.42)
SCHEMBL14692143 0.54 ADRA1B (0.47)
SCHEMBL6393905 0.52 ADORA2B (0.49) PARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3230273-A1 2,4-DIOXO-QUINAZOLINE-6-SULFONAMIDE DERIVATIVES AS INHIBITORS OF PARG Cancer Research Technology Ltd (GB) 2017-10-18 EP disclosed
WO-2016092326-A1 2,4-DIOXO-QUINAZOLINE-6-SULFONAMIDE DERIVATIVES AS INHIBITORS OF PARG CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2016-06-16 WO disclosed